PIERIS PHARMACEUTICALS, INC. PIRS Cash Flow

Pieris pharmaceuticals, inc. (PIRS)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13
Operating activities:
Net loss
-18,718	-25,469	-36,380	-39,943	-28,388	-26,754	-7,581	-8,485	-18,367	-17,647	-31,696	-30,833	-26,631	-22,799	-19,142	-16,868	-14,514	-14,058	-15,323	-13,423	-12,774	-9,849	0	0	0	-	-
Net loss for the period
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-24	-15	0	0	0
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation
805	632	532	503	602	570	537	462	434	400	453	491	366	361	249	236	324	307	322	332	349	366	0	0	0	-	-
Right-of-use asset amortization
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,589	0	0	0	-	-
Stock-based compensation
5,367	5,374	5,538	5,330	5,229	4,943	4,749	4,089	3,298	3,046	2,440	2,236	2,288	1,905	1,767	1,659	1,315	1,164	0	0	0	-	-	-	-	-	-
Non-cash restricted shares
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	446	0	0	0	-	-	-	-	-	-
Other non-cash transactions
-329	69	-541	130	231	-75	170	-324	-301	-293	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities
0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-70	0	0	0	-	-
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-465	0	0	0	-	-
Prepaid expenses and other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	1,020	2,649	1,003	1,714	1,256	0	0	0	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	3,752	0	0	0	-	-	-	-	-	-	-	-	-	-
Prepaid expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-
Accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	1,360	3,262	-637	65	-90	1,069	1,525	1,186	1,115	0	0	0	-	-
Accrued expenses and other current liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	2,063	1,504	1,106	1,307	556	504	315	65	-136	0	0	0	-	-
Income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-
Net cash provided by operating activities
-	-	-	-	-	-	-	-	-	-	47,718	8,944	9,356	-14,388	-10,150	-10,112	-7,085	-12,705	-10,193	-8,335	-8,240	-5,065	0	0	0	-	-
Increase (Decrease) in Accrued Liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Net cash used in operating activities
-52,490	-52,467	-47,551	-49,258	-47,513	-1,066	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-24	-15	0	0	0
Investing activities:
Purchases of property and equipment
4,268	2,462	1,851	1,944	1,405	1,698	1,952	1,916	2,185	1,950	1,368	1,277	671	560	674	671	648	620	531	336	306	267	4	4	0	0	0
Proceeds from maturity of investments
88,856	63,325	85,635	113,031	87,600	88,358	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from maturity of investments
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of investments
77,312	59,317	99,329	77,357	114,140	117,582	110,940	111,147	55,404	43,925	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) investing activities
15,568	9,838	6,502	55,777	-5,898	-8,875	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing activities:
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-1,368	-1,277	-671	-560	-674	-671	-648	-620	-522	-336	-306	-267	0	0	0	-	-
Proceeds from Stock Options Exercised
-	-	-	-	-	1,000	1,398	1,442	1,607	781	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from Warrant Exercises
-	-	-	-	-	300	496	2,204	3,435	3,309	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from Issuance of Common Stock
-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Proceeds from director loans
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Net cash provided by financing activities
32,166	32,166	508	563	352	48,511	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	29	26	0	0	0
Effect of exchange rate change on cash and cash equivalents
93	-2,144	-2,873	-2,757	-4,368	-1,581	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net decrease in cash and cash equivalents
-4,663	-12,607	-43,414	4,325	-57,427	36,989	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,157	0	0	0	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	3,492	1,405	15,221	15,221	15,231	41,067	25,743	24,616	0	0	0	-	-	-	-	-	-
Effect of exchange rate change on cash and cash equivalents
-	-	-	-	-	-	-	-	-	553	3,518	876	147	-267	-103	62	11	-414	-429	-723	-762	-215	0	0	0	-	-
Net increase in cash and cash equivalents
-	-	-	-	-	-	-	-	-	8,522	53,362	9,948	24,052	6	4,302	30,347	18,021	10,874	30,758	8,542	9,897	14,784	-2,192	-2,208	0	0	0
Supplemental cash flow disclosures:
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	206	35	34	48	71	0	0	0	-	-
Net unrealized gain on investments
-270	14	54	-893	1,708	681	276	847	-1,517	-820	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property and equipment included in accounts payable
1,825	1,235	217	70	176	241	215	297	-434	114	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash received for income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-